English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduSeptember is Gynecologic Cancer Awareness Month. Rutgers Cancer institute of New Jersey Gynecologic Oncology Chief Dr. James Aikins reminds women about the types of gynecologic cancers and their warning signs
Tag: Rutgers Cancer Insstitute of New Jersey
Understanding Emotional Health and Childhood Cancer
Karen Long-Traynor, PhD, clinical psychologist in the Pediatric Hematology/Oncology Program at Rutgers Cancer Institute of New Jersey, addresses the psychological effects of childhood cancer on children and their families.
Rutgers Cancer Institute of New Jersey Experts Available for Comment during Men’s Health Month
New Brunswick, N.J., June 7, 2021 – June is a special time of year focused on heightening the awareness of preventable health problems and encouraging early detection and treatment of disease for men. Diseases like prostate cancer, which is the…
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Present Extensive, Wide-Ranging New Cancer Research Data at the 2021 ASCO Annual Meeting
Rutgers Cancer Institute of New Jersey, a leader in cutting-edge clinical trials and health outcomes analyses and a designated Comprehensive Cancer Center by the National Cancer Institute, together with RWJBarnabas Health, today announced that data from its cancer clinical research program will be presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held virtually from June 4-8.
Rutgers Cancer Institute of New Jersey Research Leader Elected as a Fellow to the American Association for Cancer Research Academy
Deputy director, chief scientific officer, and associate director for Basic Research at Rutgers Cancer Institute of New Jersey has been elected to the 2021 class of Fellows of the American Association for Cancer Research (AACR) Academy, a prestigious accolade offered only to individuals whose work has had a significant and enduring impact on cancer research.
Multiple Myeloma Explained
Expert from Rutgers Cancer Institute of New Jersey shares information on symptoms, treatment and more to highlight multiple myeloma awareness month.
Exploring Racial and Ethnic Disparities in Colorectal Cancer Screening among Patients with Diabetes
Researcher at Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Medical School has received $400,000 in awards to help identify and overcome multi-level factors such as patient, health professionals and clinic systems affecting optimal use of colorectal cancer preventative screening options for patients with elevated medical and social risks throughout the United States.
Shedding light on the Forgotten Cancer
Rutgers Cancer Institute expert sheds light on sarcoma for rare disease day.
Our Role in Beating Cancer Together in New Jersey and Beyond
This year’s theme for World Cancer Day 2021 — “Together, all our actions matter” — calls for individuals to reflect on the idea that collaboration and collective action make us stronger in the fight against cancer and spreads the powerful message that we all have a role to play in reducing the global impact of the disease. At Rutgers Cancer Institute of New Jersey in partnership with RWJBaranabas Health, experts are always working toward the goal of helping individuals fight cancer through onsite research, clinical trials and collaborations with teams locally and across the globe. Learn more about how.
Identification of Tamoxifen Resistance Markers Can Play Role in Breast Cancer Treatment Planning
In a recent study, researchers from Rutgers University explored the therapeutic response to Tamoxifen, a drug that blocks the activity of estrogen to the breast, in estrogen-receptor (ER) positive breast cancer by using a computational framework to predict treatment resistance based on behavior of molecular pathways.
Rutgers Cancer Institute of New Jersey Chair of Radiation Oncology and Associate Vice Chancellor Named President-Elect of the RSNA Board
The Radiological Society of North America (RNSA) is an international society of radiologists, medical physicists and other medical professionals across the world, with the mission of promoting excellence in patient care and health care delivery through education, research and technologic innovation. This year, Bruce G. Haffty, MD, associate vice chancellor for cancer programs and chair, radiation oncology at Rutgers Cancer Institute of New Jersey has been named president-elect of the society.